Givastomig is designed to simultaneously target CLDN18.2 and 4-1BB. CLDN18.2 is a tight junction protein that is typically ...

Stem cells are gaining attention for their potential to treat leukemia, certain solid tumor cancers, and inherited metabolic ...

Telangana’s Musi Riverfront Development Project aims to revive the polluted river and transform Hyderabad’s waterfront. But land acquisition, lack of transparency, and the proposed Gandhi Sarovar have ...

Encouraging preclinical and translational data supporting DNase-based approaches to target NETs in difficult-to-treat ...

Pembrolizumab plus weekly paclitaxel, with investigator-choice bevacizumab, achieved statistically significant PFS and OS improvements, addressing a high unmet need in platinum-resistant ovarian ...

Solid Biosciences’ SGT-003 is the only late‑stage program to show early cardiac benefit across biomarkers and function, according to William Blair.

Solid Biosciences (SLDB) stock retains a "Strong Buy" rating, driven by robust interim data for SGT-003 in pediatric Duchenne ...

The firm is hoping to outline a potential path to accelerated approval for SGT-003 as it gears up to launch a randomized, controlled Phase III trial.

SGT-003 in the INSPIRE DUCHENNE trial to date - - Robust microdystrophin expression with consistent mechanistic evidence of dystrophin associated protein complex (DAPC) restoration and improvements in ...

Solid Biosciences (SLDB) stock dips after new Phase 1/2 trial data for SGT-003, its gene therapy for Duchenne muscular dystrophy. Read more here, ...

In any industrial process that relies on solid-liquid separation, the filter press remains one of the most reliable and widely used pieces of equipment. It delivers consistent dewatering, reduces ...

The Metropolitan Manila Development Authority is working with the World Bank Group and local government units for the ...